Stock AORT ARTIVION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Artivion, Inc.

Equities

AORT

US2289031005

Market Closed - Nyse
Other stock markets
 16:00:02 2024-06-27 EDT 		5-day change 1st Jan Change
24.85 USD +2.05% Intraday chart for Artivion, Inc. +7.58% +38.98%
05-07 Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating MT
05-07 Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Artivion: Q1 Earnings Snapshot
AQ
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
PR
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
PR
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
AQ
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
PR
Artivion: Q4 Earnings Snapshot
AQ
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
PR
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
PR
Artivion Obtains $350 Million in Senior Secured Credit Facilities
AQ
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer, Announces Retirement of D. Ashley Lee, Chief Financial Officer
AQ
Artivion Announces Completion of Enrollment in PERSEVERE Trial
PR
Artivion to Participate in Upcoming Investor Conferences
PR
Artivion Reports Third Quarter 2023 Financial Results
AQ
Artivion: Q3 Earnings Snapshot
AQ
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
PR
Artivion Announces Presentation of Real World Data from Post Market Study of On-X Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin
AQ
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
PR
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference
PR
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase
PR
Artivion to Participate in Upcoming Investor Conferences
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AORT Stock
  4. News Artivion, Inc.
  5. Press Releases